Articles From: Zoetis™ Reports First-Quarter 2013 Results to Zuoan Fashion Limited Announces Reporting Date for Fourth Quarter and Full Year 2012 Financial Results

Zoetis TM (NYSE: ZTS) , formerly the animal health business of Pfizer Inc., today reported its financial results for the first quarter of 2013.

Zoetis TM (NYSE: ZTS) , formerly the animal health business of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, April 30, 2013.

SAN DIEGO and COLUMBUS, Ohio, March 27, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, and Battelle, the world's largest independent research and development organization, today announced they have extended their co-marketing partnership for the DosePro® needle-free drug delivery system through March 29, 2014.

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the fourth quarter and full year ended December 31, 2012, before the market opens on Friday, March 15, 2013, and will hold a conference call on this day at 8:30 a.m. ET (5:30 a.m. PT), to discuss these financial results and provide a company update.

SAN DIEGO, Feb.

Provides Update on Zohydro ER Conference Call and Webcast Today, May 9, at 4:30 p.m. ET SUMAVEL ® DosePro ® (sumatriptan injection) First Quarter 2013 Highlights Net product revenue of $7.0 million, reflecting a $1.2 million net adjustment to future product return reserve Generated approximately 20,000 total prescriptions Maintained positive quarterly refill rate at 41%* Recent Highlights and Milestones Reported positive top-line results from extended Relday™ Phase 1 clinical trial; initiated efforts to secure strategic development and commercialization partner Extended DosePro® needle-free drug delivery system co-marketing partnership with Battelle SAN DIEGO, May 9, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today reported financial results for the

SUMAVEL ® DosePro ® (sumatriptan injection) Highlights Recent Highlights and Milestones Completion of the FDA review of the New Drug Application for Zohydro™ ER (hydrocodone bitartrate extended-release capsules) delayed past the Prescription Drug User Fee Act (PDUFA) target action date of March 1, 2013, with FDA indication that delay would likely be brief and last only several weeks Reported positive results for Relday™ phase 1 study; extended study to potentially accelerate development and partnering opportunities SAN DIEGO, March 15, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today reported financial results for the fourth quarter and full year ended December 31, 2012.

SAN DIEGO, May 2, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) , a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced positive top-line results from its extended Phase 1 clinical trial of Relday™, an investigational candidate of a proprietary, once-monthly subcutaneous formulation of risperidone for the treatment of schizophrenia.

BEIJING, May 17, 2013 (GLOBE NEWSWIRE) -- Zoom Technologies, Inc. (Nasdaq:ZOOM) , today announced that it will release its first quarter 2013 financial results after the close of the market on Monday, May 20, 2013.

BEIJING, April 12, 2013 (GLOBE NEWSWIRE) -- Zoom Technologies, Inc. (Nasdaq:ZOOM) , today announced that it will release its fourth quarter and full year 2012 financial results at the close of the market on Monday, April 15, 2013.

Fourth Quarter 2012 Highlights: BEIJING, April 15, 2013 (GLOBE NEWSWIRE) -- Zoom Technologies, Inc. (Nasdaq:ZOOM) (the "Company") is a holding company with a subsidiary that engages in the distribution of cellular service and products in the U.S. Today, ZOOM reported financial results for the fourth quarter and full year ended December 31, 2012.

FREMONT, Calif.

BARCELONA, Spain, Feb.

BARCELONA , Feb.

Cypress Semiconductor Corp.

Dolby Laboratories Inc. (NYSE: DLB) announced today that ZTE Corporation (ZTE) (H share stock code: 0763.HK/A share stock code: 000063.SZ) will feature Dolby ® Digital Plus™ in a wide range of ZTE smartphones and tablets, including the ZTE Grand Memo, the world’s first smartphone to be powered by Dolby Digital Plus technology, with a next-generation audio processing engine to deliver Dolby’s latest in sound technology.

http://media.marketwire.com/attachments/201304/TN-149650_CG5233.jpg CG5233 http://media.marketwire.com/attachments/201304/TN-149651_CG5213.jpg CG5213 http://media.marketwire.com/attachments/201304/TN-149652_CG5231ChipPhoto.jpg CG5231 http://media.marketwire.com/attachments/201304/TN-149653_CG5221ChipPhoto.jpg CG5221 http://media.marketwire.com/attachments/201304/TN-149654_CG5211ChipPhoto.jpg CG5211 http://media.marketwire.com/attachments/201110/33915_SigmaDesigns_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011817&ProfileId=051205&sourceType=1 MILPITAS, CA --

CHANTILLY, Va.

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996839&ProfileId=051205&sourceType=1 LYNNWOOD, WA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1015280&ProfileId=051205&sourceType=1 LYNNWOOD, WA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993905&ProfileId=051205&sourceType=1 LYNNWOOD, WA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982890&ProfileId=051205&sourceType=1 LYNNWOOD, WA --

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1005831&ProfileId=051205&sourceType=1 LYNNWOOD, WA --

Zumiez Inc. (NASDAQ:ZUMZ) , a leading specialty retailer of action sports related apparel, footwear, equipment and accessories, today announced that the Company’s conference call to discuss first quarter fiscal 2013 financial results will be broadcast live over the Internet on Thursday, May 23, 2013 at 5:00 p.m. Eastern Time and may be accessed at http://ir.zumiez.com .

Zumiez Inc. (NASDAQ:ZUMZ) a leading specialty retailer of action sports related apparel, footwear, equipment and accessories, today announced that the Company’s conference call to discuss fourth quarter fiscal 2012 financial results will be broadcast live over the Internet on Thursday, March 14, 2013, at 5:00 p.m. Eastern time and may be accessed at http://ir.zumiez.com .

Private cloud approach with FICO Capstone Decision Accelerator supports online lending decisions across multiple countries MUNICH , April 9, 2013 /PRNewswire/ --  FICO (NYSE:FICO) , a leading predictive analytics and decision management software company, today announced that ZUNO Bank AG has implemented FICO ® Capstone ® Decision Accelerator in a private cloud for its online lending business.

SHANGHAI , May 6, 2012 /PRNewswire/ -- Zuoan Fashion Limited (NYSE: ZA) ("Zuoan" or the "Company"), a leading design-driven fashion casual menswear company in China , announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2012 (the "2012 Annual Report") with the U.S. Securities and Exchange Commission ("the SEC").  The 2012 Annual Report can be accessed by visiting the SEC's website at www.sec.gov or Zuoan's website at www.zuoancn.com .

~ Company Meets Fourth Quarter Revenue Guidance Forecast & Exceeds Fourth Quarter Net Income Guidance Forecast ~~ FY12 Revenue Increased 16.0% to RMB1.4 billion from RMB 1.2 billion in FY11 ~~ FY12 Net Income Increased 15.5% to RMB295.4 million from RMB255.7 million in FY11 ~~ FY12 Diluted Earnings Per Share and ADS Increased 11.3% from FY11 SHANGHAI , April 25, 2013 /PRNewswire/ -- Zuoan Fashion Limited (NYSE: ZA) ("Zuoan" or the "Company"), a leading design-driven fashion casual menswear company in China , today announced its financial results for the fourth quarter and full year ended December 31, 2012 .

SHANGHAI , April 10, 2013 /PRNewswire-FirstCall/ -- Zuoan Fashion Limited (NYSE: ZA) ("Zuoan" or the "Company"), a leading design-driven fashion casual menswear company in China , today announced that the Company will report its fourth quarter and full year 2012 financial results before the market opens on Thursday, April 25 th , 2013.